Page last updated: 2024-09-05

erlotinib hydrochloride and Dengue

erlotinib hydrochloride has been researched along with Dengue in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barouch-Bentov, R; Bekerman, E; Einav, S; Nagamine, CM; Pu, SY; Schor, S; Xiao, F; Zanini, F1
Bekerman, E; Einav, S1
Bakken, RR; Barouch-Bentov, R; Bekerman, E; Brannan, J; De Jonghe, S; Diamond, MS; Dye, JM; Einav, S; Govero, J; Herdewijn, P; Mateo, R; Nagamine, CM; Neveu, G; Pu, SY; Randall, G; Shulla, A; Wang, S; Xiao, F1

Other Studies

3 other study(ies) available for erlotinib hydrochloride and Dengue

ArticleYear
Feasibility and biological rationale of repurposing sunitinib and erlotinib for dengue treatment.
    Antiviral research, 2018, Volume: 155

    Topics: Animals; Antiviral Agents; Cells, Cultured; Dendritic Cells; Dengue; Dengue Virus; Drug Repositioning; Erlotinib Hydrochloride; Feasibility Studies; Female; Gene Expression Profiling; Humans; Male; Mice; Mice, Inbred C57BL; Mice, SCID; Protein Serine-Threonine Kinases; Single-Cell Analysis; Sunitinib; Virus Replication

2018
Infectious disease. Combating emerging viral threats.
    Science (New York, N.Y.), 2015, Apr-17, Volume: 348, Issue:6232

    Topics: Adenine; Adenosine; Antiviral Agents; Benzamides; Chloroquine; Communicable Diseases, Emerging; Cyclosporins; Cytosine; Dengue; Drug Approval; Drug Design; Erlotinib Hydrochloride; Hemorrhagic Fever, Ebola; Humans; Imatinib Mesylate; Indoles; Organophosphonates; Piperazines; Purine Nucleosides; Pyrimidines; Pyrroles; Pyrrolidines; Quinazolines; Sunitinib; Viruses

2015
Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects.
    The Journal of clinical investigation, 2017, Apr-03, Volume: 127, Issue:4

    Topics: Adaptor Protein Complex 1; Adaptor Protein Complex 2; Animals; Antineoplastic Agents; Antiviral Agents; Cell Line, Tumor; Dengue; Dengue Virus; Drug Evaluation, Preclinical; Drug Synergism; Ebolavirus; Erlotinib Hydrochloride; Female; Hemorrhagic Fever, Ebola; Hepacivirus; Hepatitis C; Humans; Indoles; Intracellular Signaling Peptides and Proteins; Male; Mice, 129 Strain; Mice, Inbred C57BL; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Pyrroles; Sunitinib; Virus Internalization

2017